scholarly journals Caffeine Ingestion Does Not Alter Performance during a 100-km Cycling Time-Trial Performance

2002 ◽  
Vol 12 (4) ◽  
pp. 438-452 ◽  
Author(s):  
Angus M. Hunter ◽  
Allan St ◽  
Clair Gibson ◽  
Malcolm Collins ◽  
Mike Lambert ◽  
...  

This study analyzed the effect of caffeine ingestion on performance during a repeated-measures, 100-km, laboratory cycling time trial that included bouts of 1- and 4-km high intensity epochs (HIE). Eight highly trained cyclists participated in 3 separate trials—placebo ingestion before exercise with a placebo carbohydrate solution and placebo tablets during exercise (Pl), or placebo ingestion before exercise with a 7% carbohydrate drink and placebo tablets during exercise (Cho), or caffeine tablet ingestion before and during exercise with 7% carbohydrate (Caf). Placebo (twice) or 6 mg · kg−1 caffeine was ingested 60 min prior to starting 1 of the 3 cycling trials, during which subjects ingested either additional placebos or a caffeine maintenance dose of 0.33 mg · kg−1 every 15 min to trial completion. The 100-km time trial consisted of five 1-km HIE after 10, 32, 52, 72, and 99 km, as well as four 4-km HIE after 20, 40, 60, and 80 km. Subjects were instructed to complete the time trial and all HIE as fast as possible. Plasma (caffeine) was significantly higher during Caf (0.43 ± 0.56 and 1.11 ± 1.78 mM pre vs. post Pl; and 47.32 ± 12.01 and 72.43 ± 29.08 mM pre vs. post Caf). Average power, HIE time to completion, and 100-km time to completion were not different between trials. Mean heart rates during both the 1-km HIE (184.0 ± 9.8 Caf; 177.0 ± 5.8 Pl; 177.4 ± 8.9 Cho) and 4-km HIE (181.7 ± 5.7 Caf; 174.3 ± 7.2 Pl; 175.6 ± 7.6 Cho; p < .05) was higher in Caf than in the other groups. No significant differences were found between groups for either EMG amplitude (IEMG) or mean power frequency spectrum (MPFS). IEMG activity and performance were not different between groups but were both higher in the 1-km HIE, indicating the absence of peripheral fatigue and the presence of a centrally-regulated pacing strategy that is not altered by caffeine ingestion. Caffeine may be without ergogenic benefit during endurance exercise in which the athlete begins exercise with a defined, predetermined goal measured as speed or distance.

2020 ◽  
Vol 34 (3) ◽  
pp. 471-481
Author(s):  
Gabriel Barreto ◽  
Rafael Pires da Silva ◽  
Guilherme Yamaguchi ◽  
Luana Farias de Oliveira ◽  
Vitor de Salles Painelli ◽  
...  

Caffeine has been shown to increase anaerobic energy contribution during short-duration cycling time-trials (TT) though no information exists on whether caffeine alters energy contribution during more prolonged, aerobic type TTs. The aim of this study was to determine the effects of caffeine supplementation on longer and predominantly aerobic exercise. Fifteen recreationally-trained male cyclists (age 38±8 y, height 1.76±0.07 m, body mass 72.9±7.7 kg) performed a ~30 min cycling TT following either 6 mg·kg-1BM caffeine (CAF) or placebo (PLA) supplementation, and one control (CON) session without supplementation, in a double- -blind, randomised, counterbalance and cross-over design. Mean power output (MPO) was recorded as the outcome measure. Respiratory values were measured throughout exercise for the determination of energy system contribution. Data were analysed using mixed-models. CAF improved mean MPO compared to CON (P=0.01), and a trend towards an improvement compared to PLA (P=0.07); there was no difference in MPO at any timepoint throughout the exercise between conditions. There was a main effect of Condition (P=0.04) and Time (P<0.0001) on blood lactate concentration, which tended to be higher in CAF vs. both PLA and CON (Condition effect, both P=0.07). Ratings of perceived exertion increased over time (P<0.0001), with no effect of Condition or interaction (both P>0.05). Glycolytic energy contribution was increased in CAF compared to CON and PLA (both P<0.05), but not aerobic or ATP-CP (both P>0.05). CAF improved aerobic TT performance compared to CON, which could be explained by increased glycolytic energy contribution.


Author(s):  
David M. Shaw ◽  
Fabrice Merien ◽  
Andrea Braakhuis ◽  
Daniel Plews ◽  
Paul Laursen ◽  
...  

This study investigated the effect of the racemic β-hydroxybutyrate (βHB) precursor, R,S-1,3-butanediol (BD), on time-trial (TT) performance and tolerability. A repeated-measures, randomized, crossover study was conducted in nine trained male cyclists (age, 26.7 ± 5.2 years; body mass, 69.6 ± 8.4 kg; height, 1.82 ± 0.09 m; body mass index, 21.2 ± 1.5 kg/m2; VO2peak,63.9 ± 2.5 ml·kg−1·min−1; Wmax, 389.3 ± 50.4 W). Participants ingested 0.35 g/kg of BD or placebo 30 min before and 60 min during 85 min of steady-state exercise, which preceded a ∼25- to 35-min TT (i.e., 7 kJ/kg). The ingestion of BD increased blood D-βHB concentration throughout exercise (0.44–0.79 mmol/L) compared with placebo (0.11–0.16 mmol/L; all p < .001), which peaked 1 hr following the TT (1.38 ± 0.35 vs. 0.34 ± 0.24 mmol/L; p < .001). Serum glucose and blood lactate concentrations were not different between trials (all p > .05). BD ingestion increased oxygen consumption and carbon dioxide production after 20 min of steady-state exercise (p = .002 and p = .032, respectively); however, no further effects on cardiorespiratory parameters were observed. Within the BD trial, moderate to severe gastrointestinal symptoms were reported in five participants, and low levels of dizziness, nausea, and euphoria were reported in two participants. However, this had no effect on TT duration (placebo, 28.5 ± 3.6 min; BD, 28.7 ± 3.2 min; p = .62) and average power output (placebo, 290.1 ± 53.7 W; BD, 286.4 ± 45.9 W; p = .50). These results suggest that BD has no benefit for endurance performance.


Author(s):  
Adam U. Upshaw ◽  
Tiffany S. Wong ◽  
Arash Bandegan ◽  
Peter W.R. Lemon

Postexercise chocolate milk ingestion has been shown to enhance both glycogen resynthesis and subsequent exercise performance. To assess whether nondairy chocolate beverage ingestion post–glycogen-lowering exercise can enhance 20-km cycling time trial performance 4 hr later, eight healthy trained male cyclists (21.8 ± 2.3y, VO2max = 61.2 ± 1.4 ml·kg-1·min-1; M ± SD) completed a series of intense cycling intervals designed to lower muscle glycogen (Jentjens & Jeukendrup, 2003) followed by 4 hr of recovery and a subsequent 20-km cycling time trial. During the first 2 hr of recovery, participants ingested chocolate dairy milk (DAIRYCHOC), chocolate soy beverage (SOYCHOC), chocolate hemp beverage (HEMPCHOC), low-fat dairy milk (MILK), or a low-energy artificially sweetened, flavored beverage (PLACEBO) at 30-min intervals in a double-blind, counterbalanced repeated-measures design. All drinks, except the PLACEBO (247 kJ) were isoenergetic (2,107 kJ), and all chocolate-flavored drinks provided 1-g CHO·kg body mass-1·h-1. Fluid intake across treatments was equalized (2,262 ± 148 ml) by ingesting appropriate quantities of water based on drink intake. The CHO:PRO ratio was 4:1, 1.5:1, 4:1, and 6:1 for DAIRYCHOC, MILK, SOYCHOC, and HEMPCHOC, respectively. One-way analysis of variance with repeated measures showed time trial performance (DAIRYCHOC = 34.58 ± 2.5 min, SOYCHOC = 34.83 ± 2.2 min, HEMPCHOC = 34.88 ± 1.1 min, MILK = 34.47 ± 1.7 min) was enhanced similarly vs PLACEBO (37.85 ± 2.1) for all treatments (p = .019) These data suggest that postexercise macronutrient and total energy intake are more important for same-day 20-km cycling time trial performance after glycogen-lowering exercise than protein type or protein-to-carbohydrate ratio.


2013 ◽  
Vol 8 (3) ◽  
pp. 307-311 ◽  
Author(s):  
Koen Levels ◽  
Lennart P.J. Teunissen ◽  
Arnold de Haan ◽  
Jos J. de Koning ◽  
Bernadet van Os ◽  
...  

Purpose:The best way to apply precooling for endurance exercise in the heat is still unclear. The authors analyzed the effect of different preparation regimens on pacing during a 15-km cycling time trial in the heat.Methods:Ten male subjects completed four 15-km time trials (30°C), preceded by different preparation regimes: 10 min cycling (WARM-UP), 30 min scalp cooling of which 10 min was cycling (SC+WARM-UP), ice-slurry ingestion (ICE), and ice slurry ingestion + 30 min scalp cooling (SC+ICE).Results:No differences were observed in finish time and mean power output, although power output was lower for WARM-UP than for SC+ICE during km 13–14 (17 ± 16 and 19 ± 14 W, respectively) and for ICE during km 13 (16 ± 16 W). Rectal temperature at the start of the time trial was lower for both ICE conditions (~36.7°C) than both WARMUP conditions (~37.1°C) and remained lower during the first part of the trial. Skin temperature and thermal sensation were lower at the start for SC+ICE.Conclusions:The preparation regimen providing the lowest body-heat content and sensation of coolness at the start (SC+ICE) was most beneficial for pacing during the latter stages of the time trial, although overall performance did not differ.


2013 ◽  
Vol 23 (2) ◽  
pp. 187-194 ◽  
Author(s):  
Cameron P. Brewer ◽  
Brian Dawson ◽  
Karen E. Wallman ◽  
Kym J. Guelfi

Research into supplementation with sodium phosphate has not investigated the effects of a repeated supplementation phase. Therefore, this study examined the potential additive effects of repeated sodium phosphate (SP) supplementation on cycling time-trial performance and peak oxygen uptake (VO2peak). Trained male cyclists (N = 9, M ± SD VO2peak = 65.2 ± 4.8 ml · kg−1 · min−1) completed baseline 1,000-kJ time-trial and VO2peak tests separated by 48 hr, then ingested either 50 mg · kg fat-free mass−1 · d−1 of tribasic SP or a combined glucose and NaCl placebo for 6 d before performing these tests again. A 14-d washout period separated the end of one loading phase and the start of the next, with 2 SP and 1 placebo phase completed in a counterbalanced order. Although time-trial performance (55.3–56.5 min) was shorter in SP1 and SP2 (~60–70 s), effect sizes and smallest-worthwhile-change values did not differ in comparison with baseline and placebo. However, mean power output was greater than placebo during time-trial performance at the 250-kJ and 500-kJ time points (p < .05) after the second SP phase. Furthermore, mean VO2peak values (p < .01) were greater after the SP1 (3.5–4.3%), with further improvements (p < .01) found in SP2 (7.1–7.7%), compared with baseline and placebo. In summary, repeated SP supplementation, ingested either 15 or 35 d after initial loading, can have an additive effect on VO2peak and possibly time-trial performance.


2010 ◽  
Vol 5 (4) ◽  
pp. 459-468 ◽  
Author(s):  
Jeremiah J. Peiffer ◽  
Chris R. Abbiss

The use of elliptical chainrings (also called chainwheels or sprockets) has gained considerable interest in the amateur and professional cycling community. Nevertheless, we are unaware of any scientific studies that have examined the performance benefits of using elliptical chainrings during an actual performance trial. Therefore, this study examined the influence of elliptical chainring use on physiological and performance parameters during a 10 km cycling time trial. Nine male cyclists completed, in a counterbalanced order, three 10 km cycling time trials using either a standard chainring or an elliptical chainring at two distinct settings. An attempt was made to blind the cyclists to the type of chainring used until the completion of the study. During the 10 km time trial, power output and heart rate were recorded at a frequency of 1 Hz and RPE was measured at 3, 6, and 8.5 km. Total power output was not different (P = .40) between the circular (340 ± 30 W) or either elliptical chainring condition (342 ± 29 W and 341 ± 31 W). Similarly, no differences (P = .73) in 2 km mean power output were observed between conditions. Further, no differences in RPE were observed between conditions measured at 3, 6, and 8.5 km. Heart rate was significantly greater (P = .02) using the less aggressive elliptical setting (174 ± 10 bpm) compared with the circular setting (171 ± 9 bpm). Elliptical chainrings do not appear to provide a performance benefit over traditional circular chainrings during a mid-distance time trial.


Author(s):  
William H. Gurton ◽  
Steve H. Faulkner ◽  
Ruth M. James

Purpose: To examine whether an ecologically valid, intermittent, sprint-based warm-up strategy impacted the ergogenic capacity of individualized sodium bicarbonate (NaHCO3) ingestion on 4-km cycling time-trial (TT) performance. Methods: A total of 8 male cyclists attended 6 laboratory visits for familiarization, determination of time to peak blood bicarbonate, and 4 × 4-km cycling TTs. Experimental beverages were administered doubleblind. Treatments were conducted in a block-randomized, crossover order: intermittent warm-up + NaHCO3 (IWSB), intermittent warm-up + placebo, control warm-up + NaHCO3 (CWSB), and control warm-up + placebo (CWP). The intermittent warm-up comprised exercise corresponding to lactate threshold (5 min at 50%, 2 min at 60%, 2 min at 80%, 1 min at 100%, and 2 min at 50%) and 3 × 10-second maximal sprints. The control warm-up comprised 16.5 minutes cycling at 150 W. Participants ingested 0.3 g·kg body mass−1 NaHCO3 or 0.03 g·kg body mass−1 sodium chloride (placebo) in 5 mL·kg body mass−1 fluid (3:2, water and sugar-free orange squash). Paired t tests were conducted for TT performance. Hematological data (blood bicarbonate and blood lactate) and gastrointestinal discomfort were analyzed using repeated-measures analysis of variance. Results: Performance was faster for CWSB versus IWSB (5.0 [6.1] s; P = .052) and CWP (5.8 [6.0] s; P = .03). Pre-TT bicarbonate concentration was elevated for CWSB versus IWSB (+9.3 mmol·L−1; P < .001) and CWP (+7.1 mmol·L−1; P < .001). Post-TT blood lactate concentration was elevated for CWSB versus CWP (+2.52 mmol·L−1; P = .022). Belching was exacerbated pre-warm-up for IWSB versus intermittent warm-up +placebo (P = .046) and CWP (P = .027). Conclusion: An intermittent, sprint-based warm-up mitigated the ergogenic benefits of NaHCO3 ingestion on 4-km cycling TT performance.


2020 ◽  
Vol 34 (3) ◽  
pp. 471-481
Author(s):  
Gabriel Barreto ◽  
Rafael Pires da Silva ◽  
Guilherme Yamaguchi ◽  
Luana Farias de Oliveira ◽  
Vitor de Salles Painelli ◽  
...  

Caffeine has been shown to increase anaerobic energy contribution during short-duration cycling time-trials (TT) though no information exists on whether caffeine alters energy contribution during more prolonged, aerobic type TTs. The aim of this study was to determine the effects of caffeine supplementation on longer and predominantly aerobic exercise. Fifteen recreationally-trained male cyclists (age 38±8 y, height 1.76±0.07 m, body mass 72.9±7.7 kg) performed a ~30 min cycling TT following either 6 mg·kg-1BM caffeine (CAF) or placebo (PLA) supplementation, and one control (CON) session without supplementation, in a double- -blind, randomised, counterbalance and cross-over design. Mean power output (MPO) was recorded as the outcome measure. Respiratory values were measured throughout exercise for the determination of energy system contribution. Data were analysed using mixed-models. CAF improved mean MPO compared to CON (P=0.01), and a trend towards an improvement compared to PLA (P=0.07); there was no difference in MPO at any timepoint throughout the exercise between conditions. There was a main effect of Condition (P=0.04) and Time (P<0.0001) on blood lactate concentration, which tended to be higher in CAF vs. both PLA and CON (Condition effect, both P=0.07). Ratings of perceived exertion increased over time (P<0.0001), with no effect of Condition or interaction (both P>0.05). Glycolytic energy contribution was increased in CAF compared to CON and PLA (both P<0.05), but not aerobic or ATP-CP (both P>0.05). CAF improved aerobic TT performance compared to CON, which could be explained by increased glycolytic energy contribution.


Author(s):  
Sharon Gam ◽  
Kym J. Guelfi ◽  
Paul A. Fournier

Studies have reported that rinsing the mouth with a carbohydrate (CHO) solution improves cycling time-trial performance compared with rinsing with a placebo solution. However, no studies have compared the effect of mouth rinsing with a no-mouth-rinse control condition. The aim of this study was to compare the effects of a CHO mouth rinse with those of a placebo rinse and a no-rinse condition. Ten male cyclists completed three 1,000-kJ cycling time trials in a randomized, counterbalanced order. At every 12.5% of the time trial completed, participants were required to rinse their mouths for 5 s with either a 6.4% maltodextrin solution (CHO), water (WA), or no solution (CON). Heart rate and ratings of perceived exertion (RPE) were recorded every 25% of the time trial completed. Time to completion was faster in both CHO (65.7 ± 11.07 min) and CON (67.6 ± 12.68 min) than in WA (69.4 ± 13.81 min; p = .013 and p = .042, respectively). The difference between CHO and CON approached significance (p = .086). There were no differences in heart rate or RPE between any conditions. In summary, repeated mouth rinsing with water results in decreased performance relative to not rinsing at all. Adding CHO to the rinse solution appears to oppose this fall in performance, possibly providing additional benefits to performance compared with not rinsing the mouth at all. This brings into question the magnitude of the effect of CHO mouth rinsing reported in previous studies that did not include a no-rinse condition.


2013 ◽  
Vol 23 (5) ◽  
pp. 507-512 ◽  
Author(s):  
Angela L. Spence ◽  
Marc Sim ◽  
Grant Landers ◽  
Peter Peeling

Both caffeine (CAF) and pseudoephedrine (PSE) are proposed to be central nervous system stimulants. However, during competition, CAF is a permitted substance, whereas PSE is a banned substance at urinary levels >150 μg·ml−1. As a result, this study aimed to compare the effect of CAF versus PSE use on cycling time trial (TT) performance to explore whether the legal stimulant was any less ergogenic than the banned substance. Here, 10 well-trained male cyclists or triathletes were recruited for participation. All athletes were required to attend the laboratory on four separate occasions—including a familiarization trial and three experimental trials, which required participants to complete a simulated 40 km (1,200 kJ) cycling TT after the ingestion of either 200 mg CAF, 180 mg PSE or a nonnutritive placebo (PLA). The results showed that the total time taken and the mean power produced during each TT was not significantly different (p > .05) between trials, despite a 1.3% faster overall time (~57 s) after CAF consumption. Interestingly, the time taken to complete the second half of the TT was significantly faster (p < .05) in CAF as compared with PSE (by 99 s), with magnitude based inferences suggesting a 91% beneficial effect of CAF during the second half of the TT. This investigation further confirms the ergogenic benefits of CAF use during TT performances and further suggests this legal CNS stimulant has a better influence than a supra-therapeutic dose of PSE.


Sign in / Sign up

Export Citation Format

Share Document